HLB Co., Ltd.
028300
Κατάταξη σε μετοχές
#4141
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Τιμή μετοχής
$29.28
Κεφαλαιοποίηση
$3.89B
Αλλαγή (1 ημέρα)
-1.40%
Αλλαγή (1 έτος)
-8.45%
Χώρα
KR
Εμπόριο HLB Co., Ltd. (028300)
Κατηγορία
Healthcare
Δείκτης P/B για HLB Co., Ltd. (028300)
Δείκτης P/B στις October 2026 TTM: 15.65
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της HLB Co., Ltd., ο τρέχων δείκτης P/B (TTM) είναι 15.65. Στο τέλος του 2023, η εταιρεία είχε P/B δείκτη 12.31.
Ιστορικό P/B για την HLB Co., Ltd. από 2012 έως 2026
Δείκτης P/B στο τέλος κάθε έτους
| Έτος | Δείκτης P/B | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 15.65 | -5.53% |
| 2024 | 16.57 | 34.60% |
| 2023 | 12.31 | 162.53% |
| 2022 | 4.69 | -46.47% |
| 2021 | 8.76 | -19.54% |
| 2020 | 10.89 | -58.32% |
| 2019 | 26.12 | 50.87% |
| 2018 | 17.32 | -17.44% |
| 2017 | 20.97 | 262.79% |
| 2016 | 5.78 | -35.05% |
| 2015 | 8.90 | 6.84% |
| 2014 | 8.33 | 133.99% |
| 2013 | 3.56 | 31.96% |
| 2012 | 2.70 | 0.00% |
Δείκτης P/B για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Δείκτης P/B | Διαφορά Δείκτη P/B | Χώρα |
|---|---|---|---|
| 6.251 | -60.07% |
US
|
|
| 13.2547 | -15.33% |
US
|
|
| 4.208 | -73.12% |
AU
|
|
| 6.1824 | -60.51% |
NL
|
|
| - | - |
CH
|
